A phase II randomized trial of induction chemotherapy versus no induction chemotherapy followed by preoperative chemoradiation in patients with esophageal cancer
about
Recent advances in preoperative management of esophageal adenocarcinomaImportance of surveillance and success of salvage strategies after definitive chemoradiation in patients with esophageal cancer.Update on Neoadjuvant Regimens for Patients with Operable Oesophageal/Gastrooesophageal Junction Adenocarcinomas and Squamous Cell CarcinomasThe value of 18F-FDG PET before and after induction chemotherapy for the early prediction of a poor pathologic response to subsequent preoperative chemoradiotherapy in oesophageal adenocarcinoma.SEOM Clinical Guideline for the diagnosis and treatment of esophageal cancer (2016)Phase II study of bevacizumab and preoperative chemoradiation for esophageal adenocarcinoma.NEOSCOPE: A randomised phase II study of induction chemotherapy followed by oxaliplatin/capecitabine or carboplatin/paclitaxel based pre-operative chemoradiation for resectable oesophageal adenocarcinoma.Current concepts and future potential in neoadjuvant chemotherapy for esophageal cancer.The SCOPE of definitive chemoradiotherapy in locally advanced esophageal cancer: what direction for the future?Overview of different available chemotherapy regimens combined with radiotherapy for the neoadjuvant and definitive treatment of esophageal cancer.Final Results of NRG Oncology RTOG 0246: An Organ-Preserving Selective Resection Strategy in Esophageal Cancer Patients Treated with Definitive Chemoradiation.Early results of a randomized two-by-two factorial phase II trial comparing neoadjuvant chemotherapy with two and four courses of cisplatin/S-1 and docetaxel/cisplatin/S-1 as neoadjuvant chemotherapy for locally advanced gastric cancer.Change in chemotherapy during concurrent radiation followed by surgery after a suboptimal positron emission tomography response to induction chemotherapy improves outcomes for locally advanced esophageal adenocarcinoma.Trial Watch: Radioimmunotherapy for oncological indications.Long-term survival and toxicity outcomes of intensity modulated radiation therapy for the treatment of esophageal cancer: A large single-institutional cohort study.Comparative Outcomes of Induction Chemotherapy Followed By Definitive Chemoradiotherapy versus Chemoradiotherapy Alone In Esophageal Squamous Cell Carcinoma.PET-guided treatment algorithms in oesophageal cancer: the promise of the near future!Influence of induction chemotherapy in trimodality therapy-eligible oesophageal cancer patients: secondary analysis of a randomised trial.Early Metabolic Change after Induction Chemotherapy Predicts Histologic Response and Prognosis in Patients with Esophageal Cancer: Secondary Analysis of a Randomized Trial.A phase II Study Evaluating Combined Neoadjuvant Cetuximab and Chemotherapy Followed by Chemoradiotherapy and Concomitant Cetuximab in Locoregional Oesophageal Cancer Patients.18F-FDG PET Response After Induction Chemotherapy Can Predict Who Will Benefit from Subsequent Esophagectomy After Chemoradiotherapy for Esophageal Adenocarcinoma.Customization of therapy for gastroesophageal adenocarcinoma patients.
P2860
Q33589301-92E64BD5-C382-4C34-AFC7-A1478DA6E2BFQ34332847-4C193565-CA58-4ED4-9BB8-5DBC6BAE1EC3Q36284695-000EFFD9-B1C4-47D1-A29A-F4E099D8E2CFQ37433616-C0A95628-E221-432C-AC10-B68E8D24C5E6Q37475210-A35D7402-818F-411A-ADC3-A7047FFF41C1Q37525368-461AA240-0CCD-449E-A4F3-112F98738477Q37686867-4B45790C-C058-4497-A364-DEAEF9CC91E8Q38631363-E20EF330-450A-49D7-9DDB-756AF37F4136Q38854234-39126F26-0536-4F74-B930-4CBE750C2306Q39204464-D99C6BFD-F514-4BDC-9844-17311B35126CQ39301768-E421761C-3EC0-467F-AB20-25CAEC46591DQ40208907-ED3654C9-DE80-4780-89C9-AD8FB866D06BQ40766240-EBF4DA7D-7E1E-450B-8592-9BEFE53FFBEDQ43104064-AEBEBF79-38E1-4DF5-9D2F-CB43919FD852Q43267597-BFED86F5-67A8-4E45-BE1B-4EDDBB70B061Q45815728-B76DB17A-4201-45F2-AF43-5554C4D53CA3Q47156181-1905E736-3E5D-4DC0-B6D9-6FE08EE40D3DQ47318997-84E31552-EB6F-4B16-BC69-ADD2364E4FA3Q47346404-4D738182-EBC0-48A4-B319-B7A6FE47B842Q48320672-9D13FE77-7420-4528-ABCA-295F83D985A9Q52942088-89413E05-C1E1-4717-8656-CA93DD47A3E8Q55033047-7BA50F4C-639A-4912-9E1F-F286D51FAE57
P2860
A phase II randomized trial of induction chemotherapy versus no induction chemotherapy followed by preoperative chemoradiation in patients with esophageal cancer
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A phase II randomized trial of ...... atients with esophageal cancer
@en
A phase II randomized trial of ...... tients with esophageal cancer.
@nl
type
label
A phase II randomized trial of ...... atients with esophageal cancer
@en
A phase II randomized trial of ...... tients with esophageal cancer.
@nl
prefLabel
A phase II randomized trial of ...... atients with esophageal cancer
@en
A phase II randomized trial of ...... tients with esophageal cancer.
@nl
P2093
P2860
P921
P356
P1433
P1476
A phase II randomized trial of ...... atients with esophageal cancer
@en
P2093
A A Vaporciyan
P2860
P304
P356
10.1093/ANNONC/MDT339
P577
2013-08-23T00:00:00Z